Introduction
Pharmaceutical warehouses and pharmacies in Turkey form the core of the lawful medicine distribution chain. A medicine reaches the patient only after passing through a regulated system involving marketing authorization holders, manufacturers, importers, pharmaceutical warehouses, pharmacies, hospitals and public authorities. In this structure, pharmaceutical warehouses are not ordinary wholesalers, and pharmacies are not ordinary retail shops. Both operate in a heavily regulated healthcare environment where public health, medicine safety, traceability and professional responsibility are central.
Turkish law regulates this relationship through several legal instruments, including Law No. 6197 on Pharmacists and Pharmacies, the Regulation on Pharmacists and Pharmacies, the Regulation on Pharmaceutical Businesses and Products Kept in Pharmaceutical Businesses, TİTCK rules, İlaç Takip Sistemi requirements, good distribution practice principles, recall rules and inspection practice. The pharmacy regulation defines pharmacy as a healthcare institution opened under pharmacist ownership and responsible management, while Law No. 6197 defines pharmacy as a healthcare service involving medicine preparation, supply, safety monitoring, quality assurance and patient information.
The relationship between a pharmacy and a pharmaceutical warehouse is therefore not merely a purchase-sale relationship. It is a regulated supply-chain relationship. A pharmacy must obtain medicines from lawful sources, record purchases in İTS, preserve product quality, check invoices and delivery documents, manage returns correctly, handle cold-chain products properly, respond to recalls and ensure that medicines supplied to patients are safe, licensed or permitted, traceable and suitable for use.
Legal Status of Pharmaceutical Warehouses in Turkey
In Turkey, the historical term ecza deposu is still widely used in practice, but the current regulatory framework should be read together with the newer terminology of ecza ticarethanesi under the 2022 regulation. The 2022 regulation replaced the older 1999 “Ecza Depoları ve Ecza Depolarında Bulundurulan Ürünler Hakkında Yönetmelik,” and required existing pharmaceutical businesses to update their permits within the transition period.
Pharmaceutical warehouses or pharmaceutical businesses operate as authorized distribution actors. Their function is to receive, store, preserve, distribute and deliver medicines and related products under legally controlled conditions. They must comply with rules on licensing, storage, distribution, personnel, quality assurance, record-keeping, returns, recalls and inspection. The older warehouse regulation and related good distribution framework emphasized that the purpose of warehouse regulation is to ensure that pharmaceutical products and related products are supplied safely and at the required quality, and that defective, counterfeit or deteriorated products can be withdrawn from the market where necessary.
The legal role of a warehouse is different from that of a pharmacy. A warehouse is part of the wholesale and distribution level of the pharmaceutical supply chain. A pharmacy is the patient-facing healthcare institution that dispenses medicines under pharmacist responsibility. The warehouse supplies authorized recipients, while the pharmacy supplies patients through lawful prescription and pharmacy service rules.
Legal Status of Pharmacies in the Supply Chain
A pharmacy in Turkey is not a simple retail outlet. Under Turkish pharmacy law, it is a healthcare institution operated under pharmacist responsibility. The pharmacy must comply with licensing rules, prescription requirements, medicine storage standards, İTS notifications, SGK reimbursement rules, patient counseling duties and inspection obligations. The Regulation on Pharmacists and Pharmacies states that its purpose is to regulate pharmacists’ duties, powers and responsibilities and the opening, operation, relocation, transfer and closure of pharmacies.
This status determines how pharmacies may interact with pharmaceutical warehouses. A pharmacy may purchase medicines from authorized warehouses, but it cannot become a warehouse itself. The pharmacy cannot use its license to engage in wholesale distribution, supply medicines to unauthorized persons, participate in tenders as a wholesale seller or run an informal distribution network.
The Regulation on Pharmacists and Pharmacies expressly states that pharmacies cannot make wholesale sales of medicines and certain substances, while it separately recognizes that pharmacy-to-pharmacy exchange is not considered wholesale sale if performed under the applicable limits. This distinction is important because a pharmacy may need to exchange medicine with another same-province pharmacy, but it cannot use that exception as a disguised warehouse activity.
The Supply Relationship Between Warehouses and Pharmacies
The ordinary relationship between a pharmaceutical warehouse and a pharmacy begins with medicine procurement. The pharmacy orders products from an authorized warehouse, the warehouse supplies the products with proper documentation, the pharmacy receives the products, checks the delivery, records the transaction and stores the products under required conditions.
This supply relationship must be documented and traceable. The pharmacy should verify the warehouse’s authorization, product identity, invoice, delivery note, batch or serial information where applicable, expiry dates, packaging condition, cold-chain compliance and İTS notifications. The warehouse must deliver the correct product to the correct recipient under appropriate storage and transportation conditions.
The good distribution practice framework emphasizes quality assurance, written procedures, controlled storage conditions, protection from contamination, stock rotation, secure storage, timely delivery to correct addresses, effective recall plans and traceability of defective products. This means that the warehouse’s duty is not only to sell; it must preserve medicine quality throughout distribution.
For pharmacies, the practical legal rule is clear: medicines should be obtained only from lawful and traceable sources. Products obtained from unknown suppliers, informal traders, online sellers, foreign sources outside official procedures or unauthorized persons may expose the pharmacy to serious administrative, civil and criminal risks.
İlaç Takip Sistemi and Traceability
The İlaç Takip Sistemi, known as İTS, is central to the legal relationship between pharmaceutical warehouses and pharmacies in Turkey. The pharmacy regulation requires pharmacies to use İTS for medicine purchases, sales, returns, pharmacy-to-pharmacy exchanges and destruction of expired or deteriorated medicines. The regulation also requires consistency between the buyer shown in İTS notifications and the buyer identified in the related transaction documents.
This requirement directly affects warehouse-pharmacy transactions. When a pharmacy purchases medicine from a warehouse, the physical product, invoice, delivery note and İTS transaction must be consistent. If the pharmacy receives products physically but İTS does not show proper movement, later sale, SGK reimbursement or inspection may become problematic. Conversely, if İTS shows products in pharmacy stock but the physical products are missing, the pharmacy may face stock discrepancy questions.
İTS compliance protects the entire pharmaceutical chain against counterfeit products, illegal distribution, stock manipulation, false returns, recall failures and SGK irregularities. For a pharmacy, İTS is not a secondary technical system. It is legal evidence of lawful medicine movement.
Purchase Acceptance and Product Control by Pharmacies
A pharmacy should not accept warehouse deliveries mechanically. The responsible pharmacist or trained personnel should check whether the delivered products match the order, invoice and electronic records. The pharmacy should review product name, dosage, quantity, expiry date, packaging integrity, cold-chain status, batch or serial information and any visible damage.
If a product arrives damaged, expired, near expiry without disclosure, wet, overheated, frozen, improperly packaged or inconsistent with documentation, the pharmacy should not place it directly into saleable stock. The product should be quarantined, the warehouse should be contacted and the issue should be documented.
This acceptance control is especially important for cold-chain medicines, high-cost medicines, controlled products, biological medicines, oncology medicines and SGK-reimbursed specialty products. If the pharmacy later supplies a defective or improperly stored medicine to a patient, the pharmacy may face liability even if the initial error began at the warehouse level.
Cold Chain Duties Between Warehouses and Pharmacies
Cold-chain medicines are one of the most sensitive areas of warehouse-pharmacy compliance. The warehouse must store and transport cold-chain medicines under appropriate conditions, and the pharmacy must accept, store and supply them under their required conditions. The Regulation on Pharmacists and Pharmacies requires cold-chain and special-storage medicines to be accepted into the pharmacy, stored and supplied to patients in accordance with their storage requirements; it also requires pharmacies to have a refrigerator for cold-chain medicines and to keep relevant temperature and humidity monitoring records.
The warehouse’s responsibility does not end when it puts the product on a vehicle. Transportation conditions matter. The good distribution framework emphasizes that storage conditions should be continuously controlled, including during transportation. Therefore, cold-chain delivery should be supported by appropriate packaging, temperature monitoring, quick transfer and documentation.
The pharmacy’s responsibility begins at receipt. If the product arrives outside required conditions and the pharmacy still accepts and dispenses it, liability may shift or expand. A pharmacy should document any suspected cold-chain breach, contact the warehouse, quarantine the product and avoid sale until suitability is clarified.
Returns from Pharmacies to Warehouses
Returns are a major compliance area in the relationship between warehouses and pharmacies. A pharmacy may need to return products because of wrong delivery, damaged packaging, recall, near-expiry arrangement, cold-chain issue, closure, force majeure or commercial return policy. However, returns must be handled through lawful procedures and proper İTS notifications.
The pharmacy regulation requires İTS notifications for returns to the warehouse from which medicines were obtained and, in force majeure or pharmacy closure situations, returns to another warehouse under the applicable framework. This means that a physical return without electronic and documentary consistency is risky.
A lawful return file should show the product, quantity, serial or batch information, reason for return, warehouse identity, date, document number and İTS notification. Cold-chain returns should include temperature control considerations. Controlled medicines and high-cost products should receive enhanced documentation.
Expired and Deteriorated Medicines
Expired and deteriorated medicines cannot be treated as ordinary returnable stock unless the law and warehouse policy specifically allow a lawful route. The pharmacy regulation requires expired or unusable medicines to be listed by the pharmacy owner or responsible manager, and the pharmacy must apply to the provincial health directorate for destruction. The destruction process is documented with the provincial health directorate and chamber of pharmacists representatives, notified to the tax office, and the report must be preserved at the pharmacy.
This is important because a pharmacy cannot simply send expired medicines back to a warehouse informally to remove them from its shelves. If the products are expired or deteriorated, the pharmacy must determine the correct legal procedure. İTS destruction notification must also match the physical and official process.
If a warehouse accepts expired or deteriorated products under a lawful return or destruction arrangement, the documentation must be clear. Otherwise, products may appear to move within the supply chain despite being unsuitable for patient use.
Recalls and Market Withdrawal
Recalls are one of the most important points of cooperation between pharmaceutical warehouses and pharmacies. If a product is defective, counterfeit, contaminated, mislabeled, unstable, recalled by TİTCK or withdrawn by the authorization holder, the warehouse and pharmacy must respond quickly.
The good distribution framework requires an effective recall plan and traceability system to identify defective products. Warehouses must be able to inform pharmacies about affected batches, stop further distribution and organize product return or quarantine. Pharmacies must identify affected stock, remove products from sale, preserve records and follow the recall instructions.
For pharmacies, recall compliance requires organized stock and records. If the pharmacy cannot identify whether it has received or dispensed a recalled batch, patient safety and legal defense become difficult. İTS records, invoices, warehouse documents and physical stock checks should all support recall action.
Wholesale Sale Prohibition for Pharmacies
A major compliance issue is the boundary between warehouse activity and pharmacy activity. Pharmacies may purchase medicines from warehouses for patient supply, but they may not become de facto wholesalers. The pharmacy regulation prohibits wholesale sale of medicines by pharmacies.
The reason is clear. Pharmaceutical distribution must be carried out by authorized warehouse-level actors under distribution rules, while pharmacies serve patients. If pharmacies begin selling medicines wholesale, transferring large stock to other actors, participating in tenders or acting as distribution centers, the regulated supply chain is weakened.
There is a limited exception for pharmacy-to-pharmacy exchange. However, this exchange is not a substitute for warehouse distribution. It must be same-province, traceable and notified through İTS. Repeated large-volume transactions may be viewed as disguised wholesale activity.
Pharmacy-to-Pharmacy Exchange and Warehouse Relationship
Pharmacy-to-pharmacy exchange exists because pharmacies may sometimes need to support each other for patient access or stock balancing. However, exchange should not replace warehouse procurement. A pharmacy that regularly obtains stock from other pharmacies instead of warehouses may create compliance questions.
The regulation recognizes medicine exchange between pharmacies as not being wholesale sale, but limits it to pharmacies operating in the same province. The same regulatory framework requires İTS notification for pharmacy-to-pharmacy exchange.
Therefore, the normal procurement route should remain warehouse supply. Exchange should remain limited and documented. If a pharmacy routinely uses exchange as a stock procurement system, authorities may question whether the pharmacy is avoiding authorized warehouse channels, hiding stock movements or participating in informal distribution.
Contractual Relationship Between Warehouses and Pharmacies
The warehouse-pharmacy relationship also has a private law dimension. Pharmacies may have supply agreements, credit arrangements, discount protocols, payment terms, return policies, delivery schedules and dispute clauses with warehouses. These arrangements should comply with mandatory healthcare and pharmacy law rules.
A supply agreement should not encourage illegal stock movement, unlawful discounts, disguised promotion, improper prescription steering, online medicine sales or supply to unauthorized parties. It should clearly regulate order procedures, delivery documentation, cold-chain responsibility, return conditions, recall cooperation, defective product notification, payment terms, dispute resolution and data protection.
For pharmacies, the contract should not remove professional responsibility. Even if a warehouse agrees to supply quickly or take returns, the pharmacist remains responsible for lawful receipt, storage and patient supply. For warehouses, a contract should not permit delivery to unauthorized addresses or third parties.
Payment, Credit and Commercial Pressure
Warehouses may provide credit terms to pharmacies. This is common in practice, but it can create risk if commercial pressure affects professional independence. A pharmacy that becomes heavily indebted to one warehouse may feel pressured to prioritize certain products, delay returns, accept near-expiry stock or ignore product problems.
Turkish pharmacy law is built on pharmacist independence and patient safety. Commercial credit arrangements should not compromise professional judgment. The pharmacy should remain free to reject unsuitable products, report defects, return products lawfully and choose medicines according to prescription, patient need and lawful substitution rules.
Credit agreements should be transparent and documented. Hidden profit-sharing, stock-control arrangements or warehouse influence over pharmacy management may create broader risks, especially if they interfere with pharmacist independence.
Counterfeit and Unauthorized Product Risk
One of the main reasons the supply chain is regulated is to prevent counterfeit, stolen, smuggled, expired or unauthorized medicines from reaching patients. The good distribution framework emphasizes traceability, quality assurance and identification of defective products. The current packaging and tracking regulation also aims to ensure correct use of authorized products and to establish tracking systems for the distribution chain to take more effective measures against defective and counterfeit medicines.
Pharmacies should therefore avoid all non-authorized supply sources. A low price, urgent availability or patient demand does not justify obtaining medicines from unlicensed channels. If the source is not an authorized warehouse, official foreign medicine supplier or lawful pharmacy exchange partner, the pharmacy should not accept the product.
Where counterfeit suspicion arises, the pharmacy should quarantine the product, preserve documents, notify the relevant authority or supplier as appropriate, and avoid patient supply.
Records and Evidence
Records are the legal backbone of warehouse-pharmacy compliance. A pharmacy should preserve invoices, delivery notes, İTS records, return documents, destruction reports, recall communications, cold-chain records, warehouse correspondence and stock reconciliation files.
In inspections, SGK audits, patient complaints or product defect disputes, documents often decide the outcome. A pharmacist may say that a product came from an authorized warehouse, but without invoice and İTS consistency, that claim may be difficult to prove. A warehouse may say it delivered under cold-chain conditions, but without temperature records or delivery evidence, its defense may be weak.
The good distribution framework requires written procedures and records for activities affecting product quality or distribution, including acceptance, storage, cleaning, maintenance, storage-condition recording, security, order records, returns and recall plans. Pharmacies should mirror this discipline at their own operational level.
Inspections and Sanctions
Both warehouses and pharmacies may be inspected. The 2022 pharmaceutical businesses regulation framework provides that deficiencies identified during inspections may lead to time for correction, and where deficiencies are not remedied, sanctions may include suspension of activity, suspension or cancellation of permits and administrative fines. It also provides that responsible managers’ or responsible personnel’s documents may be suspended or cancelled and that product movements and İTS notifications may be stopped by the authority.
For pharmacies, inspections may examine whether medicines are sourced lawfully, İTS records match stock, expired products are separated, cold-chain conditions are monitored, returns are documented and wholesale sale prohibition is respected. Pharmacy inspection risk increases where there are unexplained stock discrepancies, repeated returns, unusual warehouse transactions, high-cost products, controlled medicines or SGK deductions.
A pharmacy should treat every warehouse transaction as potentially auditable. Compliance should not begin after inspection; it should be built into daily receiving, storage, sale and return processes.
SGK Reimbursement Risks
Warehouse-pharmacy compliance can affect SGK reimbursement. If a pharmacy dispenses a medicine under an SGK-covered prescription, it must prove that the medicine was lawfully obtained, properly recorded and supplied to the correct patient. SGK may compare MEDULA records, İTS records, purchase invoices and physical stock.
If a pharmacy cannot prove lawful acquisition from a warehouse or other permitted source, SGK may question reimbursement. This is especially important for high-cost medicines, oncology products, biological medicines, report-dependent medicines and controlled products.
A pharmacy should preserve warehouse documents for SGK-covered prescriptions. A MEDULA approval alone does not prove that the stock came from a lawful source. İTS and invoice consistency remain critical.
Liability Between Warehouse and Pharmacy
Disputes may arise between warehouses and pharmacies over wrong delivery, damaged products, late delivery, cold-chain breach, recall failures, unpaid invoices, return refusal, expiry-date problems or stock discrepancies. These disputes may have both contractual and regulatory dimensions.
If a warehouse delivers the wrong medicine and the pharmacy detects it before sale, the issue may be resolved through return. If the pharmacy fails to detect it and dispenses the wrong product, both patient liability and internal recourse claims may arise. If a cold-chain breach occurs during transport but the pharmacy accepts the product without objection, proving fault later may be difficult.
Therefore, pharmacies should document delivery conditions at the time of receipt. Warehouses should document dispatch and transport conditions. Clear evidence helps allocate responsibility fairly.
Compliance Checklist for Pharmacies
A pharmacy should apply the following checklist for warehouse relationships:
Purchase only from authorized pharmaceutical warehouses or other lawful sources.
Verify product, quantity, expiry date, packaging and invoice at delivery.
Check İTS movements and ensure consistency with documents.
Immediately quarantine damaged, suspicious, expired or incorrectly delivered products.
Document cold-chain deliveries and temperature issues.
Use lawful return procedures and İTS notifications.
Do not treat expired or deteriorated products as ordinary returns.
Follow official destruction procedures for expired and unusable medicines.
Preserve invoices, delivery notes, return documents, recall notices and İTS records.
Avoid wholesale sale and interprovincial informal distribution.
Use pharmacy-to-pharmacy exchange only within legal limits.
Monitor warehouse credit and supply agreements for compliance risks.
Train staff on receiving, stock, returns and cold-chain handling.
Compliance Checklist for Pharmaceutical Warehouses
A pharmaceutical warehouse should apply the following checklist:
Supply only authorized recipients.
Preserve product quality throughout storage and transportation.
Maintain written procedures for receiving, storage, dispatch, returns, recalls and emergencies.
Ensure cold-chain monitoring during transport.
Maintain accurate records and traceability.
Deliver correct products to correct addresses.
Respond quickly to product recalls and quality defects.
Avoid supplying pharmacies in ways that support unlawful wholesale, prescription steering or online medicine sale.
Maintain İTS and documentation consistency.
Train personnel on good distribution practice.
Prepare for inspections and internal audits.
Common Legal Mistakes
The first common mistake is treating warehouse-pharmacy transactions as ordinary commercial sales. They are regulated medicine supply transactions.
The second mistake is failing to check İTS consistency at product receipt.
The third mistake is accepting cold-chain medicines without verifying delivery conditions.
The fourth mistake is using pharmacy-to-pharmacy exchange as a substitute for warehouse distribution.
The fifth mistake is returning expired or deteriorated medicines informally instead of following legal destruction or return procedures.
The sixth mistake is failing to preserve invoices and delivery documents for SGK-covered medicines.
The seventh mistake is allowing commercial debt or warehouse pressure to compromise pharmacist independence.
The eighth mistake is ignoring recall notices or failing to check affected batches.
Frequently Asked Questions
What is the legal relationship between pharmaceutical warehouses and pharmacies in Turkey?
It is a regulated supply-chain relationship. Warehouses supply medicines under distribution rules, while pharmacies receive, store and dispense medicines under pharmacist responsibility. The relationship must comply with İTS, documentation, storage, return, recall and inspection rules.
Can pharmacies buy medicines from any supplier?
No. Pharmacies should obtain medicines only from authorized and traceable sources. Purchases from unauthorized persons, online sellers or informal channels may create serious legal risk.
Is İTS notification important in warehouse-pharmacy transactions?
Yes. Pharmacies must use İTS for purchases, sales, returns, pharmacy-to-pharmacy exchanges and destruction of expired or deteriorated medicines, and transaction documents must be consistent with İTS records.
Can pharmacies sell medicines wholesale?
No. Pharmacies are prohibited from wholesale sale of medicines. Pharmacy-to-pharmacy exchange is recognized only as a limited exception and may be made only between pharmacies operating in the same province.
What happens if warehouse or pharmacy compliance fails?
Depending on the facts, consequences may include inspection findings, correction periods, administrative fines, suspension of activity, suspension or cancellation of permits, İTS movement restrictions, SGK deductions, professional disciplinary action and civil liability.
Conclusion
Pharmaceutical warehouses and pharmacies in Turkey operate within a legally regulated medicine supply chain. Their relationship is not a simple wholesale-retail arrangement. It is a public-health-oriented compliance relationship based on authorized supply, product quality, traceability, correct documentation, İTS notifications, cold-chain protection, recall cooperation and patient safety.
Pharmaceutical warehouses must preserve product quality during storage and transport, maintain written procedures, deliver medicines to authorized recipients, keep records, manage returns and support recalls. Pharmacies must purchase only from lawful sources, check deliveries, record transactions in İTS, preserve invoices, manage cold-chain and high-risk products, avoid wholesale activity, handle returns lawfully and dispense medicines only under pharmacy law obligations.
The most important compliance point is traceability. A medicine must be traceable from lawful source to pharmacy stock and from pharmacy stock to patient supply, return, destruction or recall. İTS, invoices, delivery notes, return documents, destruction reports and stock records must tell the same story.
For pharmacists, the safest approach is daily preventive compliance. Every warehouse delivery should be checked, documented and reconciled. Every return should be legally justified and recorded. Every cold-chain product should be monitored. Every recall notice should be acted upon. Every SGK-covered product should have clear lawful stock evidence.
In Turkey, pharmaceutical warehouses and pharmacies share a common legal responsibility: protecting the integrity of the medicine supply chain. A compliant warehouse-pharmacy relationship protects patients, pharmacists, distributors, SGK, TİTCK and the public health system as a whole.
Yanıt yok